What type of study is this?

This is a Meta-Analysis study (also classified as: Systematic Review).

December 8, 2025Blood

Prophylactic immunoglobulin supplementation for infection prevention in multiple myeloma: An updated systematic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

AMAkihiro MiyashitaUniversity of Hawaiʻi at Mānoa KTKensuke TakaokaThe University of Texas MD Anderson Cancer Center

Discussion

Member takes

Implication

Systematic review shows prophylactic immunoglobulin reduces severe infections in patients with multiple myeloma, indicating efficacy of immunoglobulin in treatment protocols.

Key Points

To assess the efficacy of prophylactic immunoglobulin supplementation for infection prevention in patients with multiple myeloma.
Conducted a systematic review and meta-analysis of observational and randomized controlled trials
Compared outcomes in patients with multiple myeloma receiving prophylactic immunoglobulin versus those who did not
Utilized R software for statistical analyses
Reviewed relevant literature from PubMed, Scopus, and Cochrane CENTRAL databases.
Included 18 studies in the systematic review
Meta-analysis showed a significant reduction in severe infections (OR 0.22; p=0.005) for prophylactic immunoglobulin use
Overall infection rates did not differ significantly between groups (OR 0.97; p=0.85)
Incidence of severe infections was lower in patients treated with bispecific antibodies (OR 0.33; p=0.021)

Cite This Study

Miyashita et al. (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e4f2 https://doi.org/10.1182/blood-2025-7531

View Full Paper

Ask AI

Bookmark

Implication

Systematic review shows prophylactic immunoglobulin reduces severe infections in patients with multiple myeloma, indicating efficacy of immunoglobulin in treatment protocols.

Prophylactic immunoglobulin supplementation for infection prevention in multiple myeloma: An updated systematic review and meta-analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Prophylactic immunoglobulin supplementation for infection prevention in multiple myeloma: An updated systematic review and meta-analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider